IBI362 · GLP-1/Glucagon Dual Agonist
Dual GLP-1 and glucagon receptor agonist. Studied in metabolic research models involving adipogenesis, hepatic lipid flux, and energy expenditure.
Mazdutide (IBI362) is a weekly injectable dual agonist at the GLP-1 and glucagon receptors. Research models have studied its role in reducing body weight via dual receptor engagement, with additional interest in hepatic fat reduction compared to selective GLP-1 agents.
Store lyophilized at -20°C, protected from light. Reconstitute with bacteriostatic water. Use within 28 days refrigerated.